Hypera (FRA:HM6A) Institutional Ownership: 0.01% (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HM6A Hypera SA FRA:HM6A
80 GF Score
Price €3.58
GF Value €5.02
! 4 Warning Signs
View Full Analysis

What is Hypera Institutional Ownership?

Hypera FRA:HM6A +2.29% 80 Institutional Ownership is 0.01% as of Aug. 11, 2026. GuruFocus rates FRA:HM6A with a GF Score™ of 80/100 and a GF Value™ of €5.02. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hypera's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hypera's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hypera's Float Percentage Of Total Shares Outstanding is 0.00%.

Hypera Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Hypera's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypera Institutional Ownership Chart

Hypera Historical Data

The historical data trend for Hypera can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-06-30 2026-07-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
FRA:HM6A
80GF Score
Hypera SA FRA:HM6A
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hypera Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.01% mean?
Hypera (FRA:HM6A) has a Institutional Ownership of 0.01% as of Aug. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hypera and its competitors.
Is Hypera's Institutional Ownership too high?
Hypera's current Institutional Ownership is 0.01%. Overall, Hypera has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Hypera's Institutional Ownership compare to ZTS and UTHR?
Hypera's Institutional Ownership of 0.01% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hypera and its competitors. Hypera's current Institutional Ownership is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypera stock overvalued right now?
Hypera (FRA:HM6A) has a current Institutional Ownership of 0.01%. The stock's GF Value™ is €5.02, compared to a current price of €3.58 — trading 28.7% below its estimated fair value. The current Institutional Ownership is 0.01%. Hypera's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Hypera (FRA:HM6A), the current Institutional Ownership is 0.01% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hypera (FRA:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.58 is trading 28.7% below its estimated GF Value™ of €5.02.

Key valuation signals for FRA:HM6A:

  • Institutional Ownership: 0.01%
  • GF Value™: €5.02 vs. price of €3.58 (28.7% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
80GF Score

Get the complete analysis for FRA:HM6A

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.58
Price
€5.02
GF Value